FSSAI bans FOLINEURO Syrup, Neuherbs TRUE VITAMIN over misleading claims
Synopsis
Key Takeaways
The Food Safety and Standards Authority of India (FSSAI) on Thursday, 30 July announced strict enforcement action against several food business operators (FBOs) for misleading claims, non-compliant labelling, food safety violations, and hygiene lapses — moves the regulator described as necessary to safeguard consumer interests.
Action Against FOLINEURO Syrup
FSSAI issued a prohibition order against Vatave Health Care covering the manufacture, storage, distribution, and sale of its product 'FOLINEURO Syrup — Folinic Acid Syrup'. The regulator found that the product name 'FOLINEURO', combined with a brain image on the front of the pack, created a misleading impression that the supplement was designed to support or enhance brain and neurological functions.
Further scrutiny revealed that the product was classified as a 'Nutritional Food Supplement' — a category that does not exist under the Food Safety and Standards (Health Supplements and Nutraceuticals) Regulations, 2016. Based on the complaint, product label, licence details, and available records, FSSAI concluded that the product prima facie failed to comply with the provisions of the Food Safety and Standards Act, 2006. The prohibition takes effect immediately, and any violation will attract strict legal and penal consequences, the regulator warned.
Neuherbs TRUE VITAMIN Sale Halted
In a separate order, FSSAI prohibited the sale of 'Neuherbs TRUE VITAMIN', marketed by Global Healthfit Retail India Private Limited. The regulator held that the trade name 'TRUE VITAMIN' was misleading and not recognised under existing food regulations.
The branding was found to violate the Food Safety and Standards (Advertising and Claims) Regulations, 2018, and the Food Safety and Standards (Labelling and Display) Regulations, 2020, as it could mislead consumers about the product's nature and benefits. FSSAI directed the company to immediately halt sales, remove all misleading claims from product labels and advertisements, and submit an Action Taken Report within 30 days — failing which further regulatory action would follow.
Broader Enforcement Drive
Thursday's orders are part of a wider FSSAI crackdown that also includes prohibition orders, licence suspensions, and sale bans against other erring businesses. The regulator shared the details in a post on social media platform X, signalling a more visible enforcement posture. Notably, this action comes amid growing regulatory concern in India over nutraceutical and health supplement brands making unverified therapeutic claims on packaging — a segment that has expanded rapidly with the rise of direct-to-consumer wellness commerce.
What Consumers and Businesses Should Know
For consumers, the orders serve as a reminder that product names and imagery implying health or neurological benefits must be backed by regulatory recognition. For businesses, FSSAI's actions underscore that label categories, trade names, and visual branding are all subject to compliance scrutiny — not just ingredient lists. Companies found in violation face not just sale bans but potential licence suspension and penal proceedings under the FSS Act, 2006.
With FSSAI tightening its enforcement calendar, more such actions against non-compliant health supplement brands are expected in the coming months.